SPARC and myeloid sarcoma: In addition, in vitro analysis of moles removed during the follow-up of NTZ-treated MS patients showed a reduced expression of secreted acidic cysteine-rich protein (SPARC) and β3 integrin on melanocytic cells, proteins that are normally able to promote melanoma invasiveness.